APLT - Applied Therapeutics GAAP EPS of -$0.67 misses by $0.51
2024-05-09 07:59:34 ET
More on Applied Therapeutics
- Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
- Applied Therapeutics gets extension of FDA review for rare disease drug
- Applied Therapeutics GAAP EPS of -$1.42 beats by $0.02, revenue of $10M misses by $0.67M
- Seeking Alpha’s Quant Rating on Applied Therapeutics
- Historical earnings data for Applied Therapeutics